[Value of immunohistochemical staining with mutation-specific antibodies in detecting EGFR mutations: a meta-analysis].

about

[Value of immunohistochemical staining with mutation-specific antibodies in detecting EGFR mutations: a meta-analysis].

Item

http://www.wikidata.org/entity/Q54343325

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年学术文章

@wuu

2014年学术文章

@zh-cn

2014年学术文章

@zh-hans

2014年学术文章

@zh-my

2014年学术文章

@zh-sg

2014年學術文章

@yue

2014年學術文章

@zh

2014年學術文章

@zh-hant

name

[Value of immunohistochemical ...... R mutations: a meta-analysis].

@en

[Value of immunohistochemical ...... R mutations: a meta-analysis].

@nl

type

Item

label

[Value of immunohistochemical ...... R mutations: a meta-analysis].

@en

[Value of immunohistochemical ...... R mutations: a meta-analysis].

@nl

prefLabel

[Value of immunohistochemical ...... R mutations: a meta-analysis].

@en

[Value of immunohistochemical ...... R mutations: a meta-analysis].

@nl

P1476

[Value of immunohistochemical ...... R mutations: a meta-analysis].

@en

P2093

Chang Liu

http://www.w3.org/2001/XMLSchema#string

Chao Ning

http://www.w3.org/2001/XMLSchema#string

Diansheng Zhong

http://www.w3.org/2001/XMLSchema#string

Jing Wang

http://www.w3.org/2001/XMLSchema#string

Ping Xiao

http://www.w3.org/2001/XMLSchema#string

Qing Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Somatic mutations of the epidermal growth factor receptor and non-small-cell lung cancer

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Screening for epidermal growth factor receptor mutations in lung cancer

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study

Including total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response prediction

Novel epidermal growth factor receptor mutation-specific antibodies for non-small cell lung cancer: immunohistochemistry as a possible screening method for epidermal growth factor receptor mutations.

A comparison of EGFR mutation testing methods in lung carcinoma: direct sequencing, real-time PCR and immunohistochemistry

Detection of EGFR mutations with mutation-specific antibodies in stage IV non-small-cell lung cancer.

Somatic EGFR mutation and gene copy gain as predictive biomarkers for response to tyrosine kinase inhibitors in non-small cell lung cancer.

Assessment of EGFR mutation status in lung adenocarcinoma by immunohistochemistry using antibodies specific to the two major forms of mutant EGFR.

P304

451-459

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

meta-analysis

P356

10.3779/J.ISSN.1009-3419.2014.06.03

http://www.w3.org/2001/XMLSchema#string

P407

Chinese

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2014-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24949684

http://www.w3.org/2001/XMLSchema#string

P921

immunohistochemistry

P932

6000101

http://www.w3.org/2001/XMLSchema#string